Artivion AORT Surgical sealants — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's surgical sealants — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's surgical sealants — total revenues?
- Artivion (AORT) reported surgical sealants — total revenues of $18.81M in Q1 2026.
- How has Artivion's surgical sealants — total revenues changed year-over-year?
- Artivion's surgical sealants — total revenues increased by 3.9% year-over-year, from $18.11M to $18.81M.
- What is the long-term trend for Artivion's surgical sealants — total revenues?
- Over 4 years (2021 to 2025), Artivion's surgical sealants — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $70.71M to $76.6M.
- What does surgical sealants — total revenues mean?
- This metric represents the total net sales generated from the surgical sealants product line, which includes specialized adhesives used by surgeons to manage bleeding and seal tissues during cardiac and vascular procedures. It serves as a key indicator of the company's market penetration and clinical adoption within the surgical hemostasis and tissue sealing market. Growth in this segment reflects the company's ability to expand its footprint in operating rooms through its portfolio of specialized surgical tools.